Clinical Trial Update: Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating N-acetylcysteine with continuous renal replacement therapy for rhabdomyolysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyolysis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Royal Alexandra Hospital | Conditions: Rhabdomyolysis | Phase 2 | Status: COMPLETED